Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Bennett

Showing results (181-190 of 331) with videos related to

Pageof 34
Sort By:
Expert Opinion on Drug Safety|August 18, 2023
United States' regulatory approved pharmacotherapies for nuclear reactor explosions and anthrax-associated bioterrorismCharles L Bennett, Peter Georgantopoulos, Robert Peter Gale, et al.
Expert Opinion on Drug Safety|December 11, 2014
Cardiac risks associated with antibiotics: azithromycin and levofloxacinZhiqiang Kevin Lu, Jing Yuan, Minghui Li, et al.
Breast Cancer Research and Treatment|April 28, 2016
Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancerTisha M Felder, D Phuong Do, Z Kevin Lu, et al.
Breast Cancer Research and Treatment|December 15, 2012
Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening programJoan E Cunningham, Christine A Walters, Elizabeth G Hill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screeningVeena Shankaran, June M McKoy, Neal Dandade, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 7, 2013
Strategies to improve repeat fecal occult blood testing cancer screeningTerry C Davis, Connie L Arnold, Charles L Bennett, et al.
Breast Cancer Research and Treatment|December 25, 2015
Progestin and breast cancer risk: a systematic reviewMarsha Samson, Nancy Porter, Olubunmi Orekoya, et al.
Journal of Clinical Epidemiology|April 10, 2023
Increasing FDA-accelerated approval of single-arm trials in oncology (1992 to 2020)Tatiane Bomfim Ribeiro, Charles L Bennett, Luis Enrique Colunga-Lozano, et al.
The Lancet. Haematology|December 31, 2021
Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse eventsCharles L Bennett, Krishna Gundabolu, Larry W Kwak, et al.
Expert Opinion on Drug Safety|May 21, 2011
Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedicationDennis W Raisch, Wesley Campbell, Vishvas Garg, et al.
Pageof 34

Showing results (181-190 of 331) with videos related to

Sort By:
Pageof 34
Expert Opinion on Drug Safety|August 18, 2023
United States' regulatory approved pharmacotherapies for nuclear reactor explosions and anthrax-associated bioterrorismCharles L Bennett, Peter Georgantopoulos, Robert Peter Gale, et al.
Expert Opinion on Drug Safety|December 11, 2014
Cardiac risks associated with antibiotics: azithromycin and levofloxacinZhiqiang Kevin Lu, Jing Yuan, Minghui Li, et al.
Breast Cancer Research and Treatment|April 28, 2016
Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancerTisha M Felder, D Phuong Do, Z Kevin Lu, et al.
Breast Cancer Research and Treatment|December 15, 2012
Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening programJoan E Cunningham, Christine A Walters, Elizabeth G Hill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screeningVeena Shankaran, June M McKoy, Neal Dandade, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 7, 2013
Strategies to improve repeat fecal occult blood testing cancer screeningTerry C Davis, Connie L Arnold, Charles L Bennett, et al.
Breast Cancer Research and Treatment|December 25, 2015
Progestin and breast cancer risk: a systematic reviewMarsha Samson, Nancy Porter, Olubunmi Orekoya, et al.
Journal of Clinical Epidemiology|April 10, 2023
Increasing FDA-accelerated approval of single-arm trials in oncology (1992 to 2020)Tatiane Bomfim Ribeiro, Charles L Bennett, Luis Enrique Colunga-Lozano, et al.
The Lancet. Haematology|December 31, 2021
Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse eventsCharles L Bennett, Krishna Gundabolu, Larry W Kwak, et al.
Expert Opinion on Drug Safety|May 21, 2011
Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedicationDennis W Raisch, Wesley Campbell, Vishvas Garg, et al.
Pageof 34